0001739074-24-000003.txt : 20240513 0001739074-24-000003.hdr.sgml : 20240513 20240513170913 ACCESSION NUMBER: 0001739074-24-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240513 DATE AS OF CHANGE: 20240513 EFFECTIVENESS DATE: 20240513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Soda Health, Inc. CENTRAL INDEX KEY: 0001935407 ORGANIZATION NAME: IRS NUMBER: 862230622 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-513141 FILM NUMBER: 24940228 BUSINESS ADDRESS: STREET 1: 2045 W GRAND AVE STREET 2: STE B PMB 25733 CITY: CHICAGO STATE: IL ZIP: 60612-1577 BUSINESS PHONE: (888) 713-3446 MAIL ADDRESS: STREET 1: 2045 W GRAND AVE STREET 2: STE B PMB 25733 CITY: CHICAGO STATE: IL ZIP: 60612-1577 D 1 primary_doc.xml X0708 D LIVE 0001935407 Soda Health, Inc. 2045 W GRAND AVE STE B PMB 25733 CHICAGO IL ILLINOIS 60612-1577 (888) 713-3446 DELAWARE None None Corporation true 2021 Robert Alan Knight c/o Soda Health, Inc. 2045 W Grand Ave, Ste B PMB 25733 Chicago IL ILLINOIS 60612-1577 Executive Officer Director James Daryl Risinger c/o Soda Health, Inc. 2045 W Grand Ave, Ste B PMB 25733 Chicago IL ILLINOIS 60612-1577 Executive Officer Director Jared Dauman c/o Soda Health, Inc. 2045 W Grand Ave, Ste B PMB 25733 Chicago IL ILLINOIS 60612-1577 Executive Officer Christopher Elliot Brown c/o Soda Health, Inc. 2045 W Grand Ave, Ste B PMB 25733 Chicago IL ILLINOIS 60612-1577 Executive Officer Galym Imanbayev c/o Soda Health, Inc. 2045 W Grand Ave, Ste B PMB 25733 Chicago IL ILLINOIS 60612-1577 Director Lynne Chou O'Keefe c/o Soda Health, Inc. 2045 W Grand Ave, Ste B PMB 25733 Chicago IL ILLINOIS 60612-1577 Director Mark McDade c/o Soda Health, Inc. 2045 W Grand Ave, Ste B PMB 25733 Chicago IL ILLINOIS 60612-1577 Director Other Decline to Disclose 06b false 2024-04-26 false true true false 0 9000003 8999999 4 "Total Amount Sold" includes $500,000 of Series A-3 Preferred Stock issued upon conversion of Convertible Securities. The remaining $4.00 reflects certain warrants that may be issued in connection with the Series A-3 financing". false 9 0 0 0 false Soda Health, Inc. /s/ Robert Alan Knight Robert Alan Knight Chief Executive Officer 2024-05-13